A PHASE-II STUDY OF DUP-937 (TELOXANTRONE) IN METASTATIC MALIGNANT-MELANOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCICCTG)

Citation
T. Shore et al., A PHASE-II STUDY OF DUP-937 (TELOXANTRONE) IN METASTATIC MALIGNANT-MELANOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCICCTG), Annals of oncology, 4(8), 1993, pp. 695-696
Citations number
3
Categorie Soggetti
Oncology
Journal title
ISSN journal
09237534
Volume
4
Issue
8
Year of publication
1993
Pages
695 - 696
Database
ISI
SICI code
0923-7534(1993)4:8<695:APSOD(>2.0.ZU;2-L